MiRagen raises $8.5 million for microRNA therapies that treat heart and blood disorders
Colorado-based MicroRNA upstart MiRagen Therapeutics just raised $8.5 million of a potential $20 million round, according to a regulatory filing. Its miRNA drugs are focused on correcting a number of cardiovascular,...
No comments:
Post a Comment